The company founded in 2012 with the drive to grow and support the sector in the UK. Has now expanded to 3 sites, with this role being based at their new Braintree facility into which they are investing £55 million initially and will be followed by a further £110 million over the next five years. With the aim to address challenges faced in the sector but also make this a best-in-class facility – which it already is. Added to this is that this site will be manufacturing therapies at a commercial scale and a COVID vaccine as part of the Government’s response.
Purpose of the Role:
The purpose of the role of Tech Transfer Specialist is to manage the transfer of scalable manufacturing processes into this cutting-edge facility. Overseeing the transfer of process, projects, and knowledge to the site.
Responsibilities include:
- Involvement in the end-to-end transfer of internal and external tech transfer activities - outsourced process development and / or GMP manufacturing processes
- Collaborative work with the Innovation Team and Process Development groups to manage the transfer of scalable manufacturing processes.
- Deliver project goals on time from external CMO’s working in technical collaboration and direct input into activities.
- Tech Transfer of processes both into and out of the manufacturing facility.
- Maintain of the site wide QMS
- Input into the development of projects and the design & implementation of principals at the site.
Desired Skills and Experience:
For this opportunity you will need to have:
- Demonstrable experience of GMP manufacture of ATMP’s, Biologics or related sectors
- Understanding of Upstream and / or Downstream processing
- Experience of cell culture of human ad / or mammalian cell line
- Experience in the writing of Batch Records or manufacturing protocols
- BSc or higher qualification in a relevant life science
Company Summary:
The company were established in 2012 with the purpose to make the UK the place to commercialise Cell & Gene Therapies working in collaboration with partner based in the UK, Europe, US and Asia for example. They offer cutting edge technology, services, and capabilities to take a therapy across the translational gap; into the clinic, through clinical trials to launch. Offering the capabilities to fully commercialise these life changing therapies. With the drive to continually evolve to meet the continuing needs of the sector and address the key challenges faced successfully.